[ad_1]
This was said on Sunday by American immunologist Moncef Slaoui, who leads researchers involved in the state program for the development and distribution of vaccines.
“The alternative is to give people between 18 and 55 years old a half dose of the Moderna vaccine, but twice in a row, that would allow us to vaccinate twice as many people as we have,” he told CBS.
According to the specialist, half the dose causes “exactly the same immune response” as the full dose. Therefore, this action plan is now being discussed with Moderna and the Centers for Disease Control and Prevention (CDC).
Mr. Slaoui emphasized that the vaccines should be exactly two, not one. “I think it is a more responsible approach based on available facts and data,” he said.
December 11 The United States Food and Drug Administration (FDA) approved the Pfizer-BioNTech vaccine against COVID-19. December 18 The FDA has approved the distribution of Moderna’s vaccine.
US President Donald Trump said Saturday that many US states take a long time to vaccinate the population against the coronavirus.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
